{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:57:01Z","timestamp":1777953421835,"version":"3.51.4"},"reference-count":35,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10674","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:48:41Z","timestamp":1630475321000},"source":"Crossref","is-referenced-by-count":2,"title":["Real\u2011life Cretan asthma registry focused on severe asthma: On behalf of \u2018The Cretan registry of the use of Biologics in Severe Asthma\u2019"],"prefix":"10.3892","volume":"22","author":[{"given":"Katerina","family":"Antoniou","sequence":"first","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bolaki","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Karagiannis","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Trachalaki","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despo","family":"Ierodiakonou","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vagia","family":"Stamatopoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charito","family":"Chatzinikolaou","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semeli","family":"Mastrodimou","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Stamataki","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Pitsidianakis","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Lambiri","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Mitrouska","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Tzanakis","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University Hospital of Heraklion, University of Crete, 71003\u00a0Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"key20211014132440_b1-etm-22-5-10674"},{"key":"key20211014132440_b2-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"1900588","key":"key20211014132440_b3-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: A European respiratory society\/American thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J"},{"key":"key20211014132440_b4-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1183\/16000617.00008114","article-title":"National and regional asthma programmes in Europe","volume":"24","author":"Selroos","year":"2015","journal-title":"Eur Respir Rev"},{"key":"key20211014132440_b5-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/1744666X.2019.1574571","article-title":"Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: Systematic review of 42 studies published 2008-2018","volume":"15","author":"MacDonald","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"1753466618810192","key":"key20211014132440_b6-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1177\/1753466618810192","article-title":"Omalizumab, the first available antibody for biological treatment of severe asthma: More than a decade of real-life effectiveness","volume":"12","author":"Pelaia","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"key20211014132440_b7-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40259-016-0182-5","article-title":"Mepolizumab: A review in eosinophilic asthma","volume":"30","author":"Deeks","year":"2016","journal-title":"BioDrugs"},{"issue":"1902420","key":"key20211014132440_b8-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02420-2019","article-title":"Mepolizumab effectiveness and identification of super-responders in severe asthma","volume":"55","author":"Harvey","year":"2020","journal-title":"Eur Respir J"},{"key":"key20211014132440_b9-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jaci.2018.09.033","article-title":"Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma","volume":"143","author":"Khatri","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"key20211014132440_b10-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key20211014132440_b11-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jaip.2014.05.005","article-title":"The prevalence of severe asthma and low asthma control among Danish adults","volume":"2","author":"von B\u00fclow","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key20211014132440_b12-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.chest.2019.10.051","article-title":"International severe asthma registry: Mission statement","volume":"157","year":"2020","journal-title":"Chest"},{"issue":"P3936","key":"key20211014132440_b13-etm-22-5-10674","article-title":"Asthma and asthma-like symptoms in Greece. The Greece asthma national prevalence survey","volume":"40 (Suppl 56)","author":"Zervas","year":"2012","journal-title":"Eur Respir J"},{"key":"key20211014132440_b14-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/02770903.2018.1471704","article-title":"The self-reported prevalence and disease burden of asthma in Greece","volume":"56","author":"Kourlaba","year":"2019","journal-title":"J Asthma"},{"key":"key20211014132440_b15-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"key20211014132440_b16-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"00289","DOI":"10.1183\/23120541.00289-2019","article-title":"Validation of online asthma control questionnaire and asthma quality of life questionnaire","volume":"6","author":"Khusial","year":"2020","journal-title":"ERJ Open Res"},{"key":"key20211014132440_b17-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"00125","DOI":"10.1183\/23120541.00125-2017","article-title":"An algorithmic approach for the treatment of severe uncontrolled asthma","volume":"4","author":"Zervas","year":"2018","journal-title":"ERJ Open Res"},{"issue":"1700053","key":"key20211014132440_b18-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00053-2017","article-title":"Severe asthma: Phenotyping to endotyping or vice versa?","volume":"49","author":"Papi","year":"2017","journal-title":"Eur Respir J"},{"key":"key20211014132440_b19-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40258-019-00469-4","article-title":"The Economic burden of asthma in Greece: A cross-sectional study","volume":"17","author":"Vellopoulou","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"issue":"67","key":"key20211014132440_b20-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00067","article-title":"Direct and indirect costs of asthma management in Greece: An expert panel approach","volume":"5","author":"Souliotis","year":"2017","journal-title":"Front Public Health"},{"issue":"1701109","key":"key20211014132440_b21-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01109-2017","article-title":"An invisible disease: Severe asthma is more than just \u2018bad asthma\u2019","volume":"50","author":"Wenzel","year":"2017","journal-title":"Eur Respir J"},{"issue":"1901163","key":"key20211014132440_b22-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01163-2019","article-title":"Characteristics and treatment regimens across ERS SHARP severe asthma registries","volume":"55","author":"van Bragt","year":"2020","journal-title":"Eur Respir J"},{"issue":"1495039","key":"key20211014132440_b23-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1495039","article-title":"The portuguese severe asthma registry: Development, features, and data sharing policies","volume":"2018","author":"S\u00e1-Sousa","year":"2018","journal-title":"Biomed Res Int"},{"key":"key20211014132440_b24-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"00092","DOI":"10.1183\/23120541.00092-2019","article-title":"Prevalence of oral corticosteroid use in the German severe asthma population","volume":"5","author":"Taube","year":"2019","journal-title":"ERJ Open Res"},{"issue":"1701782","key":"key20211014132440_b25-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01782-2017","article-title":"Care pathways for the selection of a biologic in severe asthma","volume":"50","author":"Bousquet","year":"2017","journal-title":"Eur Respir J"},{"issue":"80","key":"key20211014132440_b26-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-12-80","article-title":"Factors associated with patient visits to the emergency department for asthma therapy","volume":"12","author":"AL-Jahdali","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"P2263","key":"key20211014132440_b27-etm-22-5-10674","article-title":"Managing asthma in the outpatient clinic: Is the diagnosis of asthma confirmed objectively according to guidelines?","volume":"40 (Suppl 56)","author":"Stensen","year":"2012","journal-title":"Eur Respir J"},{"key":"key20211014132440_b28-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/ACI.0000000000000549","article-title":"Biological treatments for severe asthma","volume":"19","author":"Assaf","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"key20211014132440_b29-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"key20211014132440_b30-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.201810-1974ED","article-title":"New biologics for severe asthma: What patients, what agents, what results, at what cost?","volume":"199","author":"Rabe","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"190054","key":"key20211014132440_b31-etm-22-5-10674","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0054-2019","article-title":"Severe T2-high asthma in the biologics era: European experts' opinion","volume":"28","author":"Pavord","year":"2019","journal-title":"Eur Respir Rev"},{"key":"key20211014132440_b32-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.anai.2019.10.016","article-title":"Asthma biologics: Comparing trial designs, patient cohorts and study results","volume":"124","author":"Doroudchi","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20211014132440_b33-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cea.13809","article-title":"Switching between biologics in severe asthma patients. When the first choice is not proven to be the best","volume":"51","author":"Papaioannou","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"key20211014132440_b34-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jaip.2020.10.048","article-title":"How to assess effectiveness of biologics for asthma and what steps to take when there is not benefit","volume":"9","author":"Pepper","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key20211014132440_b35-etm-22-5-10674","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1159\/000508559","article-title":"Mepolizumab in severe eosinophilic asthma: A 2-year follow-up in specialized asthma clinics in Greece: An interim analysis","volume":"181","author":"Kallieri","year":"2020","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T12:59:38Z","timestamp":1634216378000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10674","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"article-number":"1239"}}